More stories

  • in

    As India resists calls for a national lockdown, one economist says states should decide

    Prime Minister Narendra Modi is under growing pressure to call for another nationwide lockdown in India as the overwhelmed health-care system struggles to fight a devastating second Covid-19 wave.But one member of Modi’s economic advisory council says state governments should have the final say in social restrictions instead.”All things considered, the current policy of leaving it to different states, to take local circumstances into account, and decide on a lockdown strategy – I think it is a better one on balance,” V. Anantha Nageswaran, part-time member of the Economic Advisory Council to the Prime Minister, told CNBC’s “Squawk Box Asia” on Tuesday.Calls for a national lockdown — like the one imposed last year between late-March and May — have grown louder as India’s health-care system buckles, and patients are turned away due to shortages of hospital beds, medical oxygen and medicines needed to treat the disease.Top White House coronavirus advisor Anthony Fauci also said in an interview with ABC News on Sunday that India needs to shut down in order to break the chains of transmission.So far, the central government has resisted calls for a lockdown, allowing states to step up their own localized restrictions, including lockdowns and curfews.Instead, the government is focusing its efforts on delivering global aid received — including oxygen concentrators, cylinders, and generation plants as well as anti-viral drug Remdesivir — to affected areas. The country is also stepping up its vaccination campaign.People aged 18 and over waiting to be inoculated against Covid-19 at a vaccination centre at Radha Soami Satsang grounds being run by BLK-Max hospital on May 4, 2021 in New Delhi, India.Hindustan Times | Hindustan Times | Getty ImagesNageswaran explained that at this point, the benefits of a nationwide lockdown will not significantly outweigh the costs. He added that the surge in cases is still relatively localized in different pockets instead of at a national level.India has reported more than 300,000 daily cases for 20 consecutive days. On Tuesday, however, the health ministry said its data showed a net decline in the total active cases over a 24-hour period for the first time in 61 days.India’s death toll from the coronavirus is close to 250,000.Economic growth trajectoryLast year’s national lockdown knocked India off its growth trajectory, pushing the economy into a technical recession. Prior to the second wave of infections, the economy was slowly on the mend — but economists are now predicting the recovery will be delayed in light of the current situation.There is a growing possibility that localized lockdowns will likely continue until June or beyond, and given the current pace of vaccination, any attempt to fully reopen the economy could result in a potential third wave of infections, Kunal Kundu, India economist at investment bank Societe Generale, said in a recent note.Kundu said the bank had a forecast of 9.5% year-on-year real GDP growth for India’s fiscal year ending in March 2022, that was below market consensus. But even that target is no longer tenable as it was based on the assumption that the economy will open up sooner due to a rapid pace of vaccination.”With localised lockdowns until June and beyond, this adds downside risk to our existing growth forecast. We now expect real GDP to clock growth of 8.5% for the current year,” Kundu said.India’s Covid crisisRead CNBC’s latest coverage of India’s battle with the coronavirus pandemic:WHO labels a Covid strain in India as a ‘variant of concern’ — here’s what we knowIndia’s worsening Covid crisis could spiral into a problem for the worldIndia is the home of the world’s biggest producer of Covid vaccines. But it’s facing a major internal shortageIndia’s economy will likely contract this quarter as Covid cases soar, economists warnHe added that India’s ability to track the new variants will be key to preventing subsequent waves. For that, the country “needs to earmark more fiscal resources for genomic surveillance and vaccine research,” and ensure all temporary Covid-19 care centers are still operational, he said.Nageswaran added that if India’s Covid-19 cases do not peak in the next two weeks, and if it drags into the next quarter, the country’s pre-pandemic level growth trajectory will be harder to achieve until the 2022-2023 financial year. More

  • in

    4 steps to take to achieve socially responsible investment goals, according to a consultant

    With sustainable investments becoming an increasing part of the international agenda, pressure is piling on businesses to ensure they have a suitable strategy in place.BlackRock — the world’s largest asset manager and a forerunner in sustainable investments — was last week accused of inconsistency in its ESG agenda. ESG stands for environmental, social and corporate governance, and refers to a set of standards that measure a company’s performance in areas like carbon emissions and social responsibility.The investment firm was found to have links to an Indonesian palm oil company, which once again raised concerns around possible blind spots in the ESG investment process. But according to Singapore-based consultancy Asia Research and Engagement (ARE), there are several steps businesses can take to ensure their ESG strategy is considered and consistent.It’s no good having a commitment for 2050 and expecting all of the change to happen in 2049.Benjamin McCarronfounder and managing director, Asia Research and EngagementFirst, businesses must set out a strong intention to “manage whatever it is that needs to be managed,” Benjamin McCarron, founder and managing director of ARE told CNBC Tuesday. That could be internal policies or external investments.Then, leaders should set in place a time-targeted plan to meet those goals.”It’s no good having a commitment for 2050 and expecting all of the change to happen in 2049, so there needs to be a plan which is in place and which is progressive through time,” he said.An Acehnese worker harvests palm oil fruits at a palm oil plantation area in Kuta Makmur, North Aceh Regency.SOPA Images | LightRocket | Getty ImagesNext, they need to implement a transparent reporting system and have appropriate governance in place to ensure that reporting is adhered to.Finally, businesses need to start now. “Don’t leave it too late,” said McCarron.The advice comes as interest in ESG investments has been rising. In the first quarter of 2021, investments in sustainable funds hit a new high of nearly $2 trillion, marking the fourth quarter of gains, according to Morningstar.However, investors should continue to exercise caution to ensure companies are acting in accordance with their claims. Institutional investors should engage in dialogue, exert their voting rights and implement shareholder proposals to make sure companies are meeting the set goals.Meanwhile. it’s much easier for retail investors, said McCarron: “You can have whatever values you want. If you don’t want to own something, don’t own it.” More

  • in

    ‘CDC's credibility is eroding' amid conflicting mask guidance, ex-Obama official says

    Dr. Kavita Patel is slamming the Centers for Disease Control and Prevention for not effectively updating its Covid mask guidance. “I think the CDC’s credibility is eroding as quickly as the cases of coronavirus are eroding,” said Patel on CNBC’s “The News with Shepard Smith.” “That’s not good news, because, we do need workplace guidance, we need school guidance.” “There are men and women working on the lines outside on telephone and electricity lines, and they’re still wearing masks because, in the absence of this guidance, we’re making it up,” Patel said. “That actually puts more of us at risk, so this is time to step up. These are the hard parts of government and public health communication, but we desperately need someone to do it.”Maine Republican Senator Susan Collins has said her confidence in the agency is being undermined by conflicting CDC guidance.”I used to have the utmost respect for the guidance from the CDC,” Collins said during a Congressional hearing on the pandemic response Tuesday. “I always considered the CDC to be the Gold Standard. I don’t anymore.”The CDC did not immediately respond to CNBC’s request for comment.Meanwhile, Alaska Republican Senator Lisa Murkowski has said federal mask requirements were endangering the work of fishermen.”You’re out on a boat. The winds are howling. Your mask is soggy wet,” Murkowski said during the hearing. “Tell me how anybody thinks that this is a sane and a sound policy?” Patel, who served in the Obama Administration as director of policy for the Office of Intergovernmental Affairs and Public Engagement, echoed Murkowski’s concerns.  More

  • in

    Consumer-price inflation in America jumps up to 4.2%

    AS AMERICA’S ECONOMY bounces back from the pandemic, aided by trillions of dollars of fiscal stimulus, the main question on investors’ mind is if and when inflation will take off. The Federal Reserve has vowed to tolerate a period of above-target price increases so that the economy can get back on its feet, and says it is not even thinking about thinking about raising interest rates. Yet with a raft of asset prices underpinned by rock-bottom rates, investors have been jumpy, fretting that high inflation could force the central bank’s hand. Then on May 12th came a big inflation surprise. America’s consumer-price index rose by 4.2% year-on-year in April, a rate not seen since 2008, and considerably higher than the 3.6% that had been expected by forecasters (see chart). By far the biggest factor behind the acceleration relates to the past, rather than the price pressures of today, as last year’s oil-price falls dropped out of the annual comparison used to calculate the figures. Yet even the monthly rate, when stripped of more volatile food and energy prices, was the strongest since the 1980s. Data for one month alone cannot answer the question of whether runaway inflation is around the corner. But the release tells you something about the realities of re-opening.Consumer demand in the world’s largest economy is making an especially strong recovery. Stimulus cheques worth up to $1,400 were doled out to many Americans in the spring. Now a successful vaccination campaign is allowing them to get out and spend and restrictions to loosen. According to a tracker compiled by JPMorgan Chase, a bank, credit-card spending rose from a tenth below its pre-pandemic trend in the six months to March to only just below it by May. The speed and nature of the post-lockdown bounceback seems to have caught many firms off guard. Not since the mid-1970s have companies been so likely to report delays in supplier deliveries, suggests research published in March by Goldman Sachs, a bank. American retailers’ inventories, relative to revenues, have plunged to all-time lows, suggesting that shops are running out of things to sell. Many firms, especially smaller ones, have ordered insufficient supplies and are now frantically catching up. (By contrast, the inventories of large listed firms have not declined, either because they were better able to forecast the coming spending binge, or because their supply chains are more diversified.) Yet surges in demand cannot immediately be fulfilled. Take imported supplies, for instance. Even at the best of times extra demand for international deliveries takes a while to sate; a ship can take a few weeks to sail from China to America. The added complication in 2021 is that firms must also contend with shortages of containers in some ports. Some were stranded during the first wave of lockdowns. Moreover, workers cannot be hired overnight. Firms are struggling to recruit enough staff to fill open positions—perhaps a big reason why the jobs report for April, published on May 7th, showed that America had added just 266,000 jobs, well below the 1m or so that many economists had expected. The number of unfilled positions is running at an all-time high.Take the surge in demand and strained supply together, and you get to higher prices. Consider used cars and trucks as a template. Their prices rose by a staggering 10% in April, compared with the previous month, contributing to the headline-inflation surprise. With people nervous of flying and public transport, more may want to get behind the wheel instead to see relatives in other parts of the country or to get to work. Yet the shortage of chips has also constrained the supply of new vehicles. Once assured of sustained demand, other companies may also begin to pass on higher costs to customers. The cost of shipping items from China to America is now three times as expensive as it was before the pandemic, and input prices have picked up since the spring. What, if anything, can these pressures tell you about inflation to come? In order for it to stay high, such price rises will need to keep repeating, pushing up wages in turn. Yet they could reasonably be a one-off, as suppliers adjust to shifting consumer tastes. Even as economies locked down in early 2020, for instance, firms quickly found new ways of sourcing material and bottlenecks cleared. The current spike would then prove transitory. That could, perhaps, explain why markets seemed to take the inflation surprise in their stride. Yet as the recovery proceeds, other surprises will come. The combination of a generous Treasury, a tolerant Fed and a pandemic puts America in uncharted territory. The one thing that is certain is that more scares cannot be ruled out.■ More

  • in

    Abbott's CEO says it has a team of 'virus hunters' to stay on top of new Covid variants

    An Abbott Labs employee gets the BinaxNOW rapid Covid-19 antigen test at her workplace.Abbott LabsAbbott Labs has a team of “virus hunters” working with health officials around the world to monitor Covid-19 variants, as some mutated strains show an ability to evade detection, CEO Robert Ford said during an interview that aired Tuesday as part of CNBC’s Healthy Returns event.”They’re constantly looking for new viruses, and in this case we set up a team to be able to monitor all the mutations that could exist,” he said of its pandemic defense coalition. “It can’t just be a U.S. thing, you have to partner with all the countries, all the universities, all the different collection sites, then I think that’s the way to go.”The Food and Drug Administration alerted clinical staff in January that new variants can cause false negative Covid-19 test results. The agency identified three tests, none of which were made by Abbott, that could be less accurate because the part of the SARS-CoV-2 genetic sequence the tests were looking for had mutated in some of the variants.Ford also made it clear that with the pace at which Covid-19 is mutating, there is no time to waste. Scientists need to “chase these mutations,” he said.In the meantime, scientists are developing a new generation of tests that look for parts of the virus that are less likely to mutate and lead to false negative results.Antigen testing, like that used in Abbott’s popular Binaxnow Covid-19 tests, targets proteins in the virus that are less likely to mutate over time. More

  • in

    Stock futures are flat after Dow's worst day since February, key inflation data on deck

    U.S. stock futures were little changed in overnight trading on Tuesday after the Dow’s worst day since February.Dow futures fell just 30 points. S&P 500 futures dropped 0.12% and Nasdaq 100 futures slipped 0.14%.On Tuesday, technology stocks fell but eventually recovered, spurring selling in the broader market. The Dow Jones Industrial Average lost 473 points, or 1.4%, dragged down by losses in Home Depot, Chevron and Goldman Sachs. The Dow experienced its worst day since February.The S&P 500 slipped 0.9%, but avoided its second straight 1% loss after Monday’s drop.The Nasdaq Composite ended the day as the relative outperformer, closing down just 0.1% after dropping more than 2% at its low of the session.During the session, the CBOE Volatility Index, a measure of fear in the markets derived by option prices on the S&P 500, jumped as high as 23.73, levels not seen in two months. Monday’s “sell-off in risk assets has continued through to this morning as we’re seeing red across the board,” said Brian Price, head of investment management for Commonwealth Financial Network. “There seems to be modest concern over inflation as of late and that has been cited as the primary catalyst for recent weakness in global equities.”Key inflation data will be released at 8:30 a.m. ET on Wednesday. April’s consumer price index is expected to grow 0.2% from the previous month, representing a 3.6% jump since last year, according to Dow Jones estimates. This jump in the headline consumer price index would be the largest since Sept. 2011. The consumer price index excluding food and energy is expected to rise 0.3% in April and 2.3% over the past 12-months.The consumer price index rose 0.6% in March from the previous month and 2.6% from a year ago, according to the Department of Labor.Investors have grown worried about the threat of inflation; however, Federal Reserve Chair Jerome Powell has said any uptick in inflation should be transitory.Become a smarter investor with CNBC Pro. Get stock picks, analyst calls, exclusive interviews and access to CNBC TV. Sign up to start a free trial today More

  • in

    J2 Global CEO says Consensus spinoff will unlock value in cloud fax and digital media businesses

    In this articleJCOMJ2 Global CEO Vivek Shah told CNBC on Tuesday the company is looking to spinoff its cloud fax service as management looks to unlock value in both businesses.The Los Angeles-based digital media company in April announced the separation plan, which would create a new publicly traded company called Consensus.”I think they’re both underappreciated and I think part of the reason they’re underappreciated is that they’re inside of one company,” Shah said in a “Mad Money” interview with Jim Cramer.”I think this is going to create a tremendous amount of value and I think it’s great to do it from a position of strength.”J2 had a market cap of $5.5 billion at the end of Tuesday.The online fax product is used primarily in the healthcare sector, where hospitals can share medical documents for patients while doing away with traditional fax machines, the company said. The fax service made up about 22% of the $1.49 billion in revenue J2 Global brought in in 2020, according to its annual report.J2 Global, whose portfolio includes the websites IGN, Mashable and Humble Bundle, is projecting that Consensus will generate as much as $342 million of revenue this year.The split will give J2 and Consensus their own dedicated leadership, focus and balance sheets, leaving the two companies with a clear set of peers to compete with, Shah said.”Consensus in the near term to me is really a play on the shift from on-prem to cloud,” he said. “Longer term, where the company is really focused is going from a document-centric to a data-centric construct.”As part of the separation, Scott Turicchi, president and chief financial office of J2, will be elevated to chief executive of Consensus. Shah will retain his seat at the top of J2.The spinoff will not require approval from shareholders, who are slated to receive about 80% of common stock in the new company.The deal is slated to close in the third quarter.Shares of J2 have rallied more than 25% from the beginning of the year. Since the announcement of the spinoff, however, the stock is down 4% at $122.83.Questions for Cramer? Call Cramer: 1-800-743-CNBCWant to take a deep dive into Cramer’s world? Hit him up! Mad Money Twitter – Jim Cramer Twitter – Facebook – InstagramQuestions, comments, suggestions for the “Mad Money” website? [email protected] More

  • in

    Stocks making the biggest moves midday: Roblox, Palantir, Tesla, Virgin Galactic & more

    Check out the companies making headlines in midday trading. Palantir — Shares of the secretive analytics and software firm rose 7.4% after it reported 49% revenue growth for its first quarter, thanks in part to the economic recoveries in the U.S. and the U.K. Palantir, which has both government and corporate clients, booked sales of $341 million in the quarter and now has 149 customers.Virgin Galactic — The space stock dropped nearly 2% amid heavy trading volume after the company gave an update on progress toward a repeat of the spaceflight test that was aborted mid-flight in December. Roblox — Shares of the online gaming platform jumped 17% after it reported a first-quarter loss of 46 cents per share on revenues of $387 million, a 140% jump on a year-over-year basis. The company also said its average daily active users were 42.1 million during the quarter, up 79% year over year.Tesla — The electric vehicle maker, the poster child for growth stocks with lofty valuations and expectations, fell about 1.8%. A Reuters report that Tesla halted plans to expand its Shanghai plant into an export hub, also fueled the sell-off.Novavax – Shares of the drug maker slid 12% after the company pushed back its timeline for seeking Covid-19 vaccine approvals. The company is not planning to apply for regulatory approval in the U.S., U.K. and Europe until the third quarter. Novavax also pushed back its timeline for full production to the fourth quarter.Affirm – Shares of the loan company dipped more than 6% after the company missed third quarter earnings estimates. Affirm posted a loss of $1.06 per share, larger than the 29-cent per share expected loss. The company did, however, beat revenue estimates. Affirm posted revenue of $230.7 million, which was ahead of the expected $198.2 million.RealReal – Shares of the luxury consignment store dropped 20% after RealReal announced that its CFO was leaving the company. BTIG also downgraded the stock to neutral, citing “stubbornly high” negative margins and a lack of further catalysts. The company reported first-quarter results on Monday that were largely in line with expectations.Hanesbrands –The apparel stock retreated more than 14% despite Hanesbrands beating expectations on the top and bottom lines in its first quarter report. The company also announced a new strategic plan that included a goal of growing its Champion brand from $2 billion in annual revenue to $3 billion by 2024.— CNBC’s Pippa Stevens, Jesse Pound and Tom Franck contributed reporting.Become a smarter investor with CNBC Pro. Get stock picks, analyst calls, exclusive interviews and access to CNBC TV. Sign up to start a free trial today More